|
THE
2008 PEGS SUMMIT...
-
includes
comprehensive coverage of topics that take you from discovery to market
-
showcases the
newest approaches and technologies in the field to enable the next
generation of biologic drugs
-
features the
first symposium on protein tomography; the clinical evaluation of
antibodies; assessment of immunogenicity in clinical trials; and protein
scale-up and manufacturing
-
offers
suggested streams to customize your event path
-
is the largest
forum focused entirely on protein engineering science to help you solve
problems that you face today, and
choose a pathway forward for tomorrow
Protein Tomography™ gives you a glimpse of biological secrets
Don’t miss the opportunity to see Sidec’s team demonstrate and guide you through two projects:
-
In a project with Genmab A/S, Protein Tomography™ has been used to study the molecular mode of action of a therapeutic antibody binding to its target,
EGFr.
-
In collaboration with Nobel laureate Prof. Roger Kornberg and his team at Stanford University, Protein Tomography™ is used to study the dynamics of RNA polymerase in solution.
The demonstrations take place Thursday, May 1 – Friday, May 2 in the Rose Kennedy foyer, just outside the Dartmouth/Eleanor room on 3rd floor, at the InterContinental Hotel.
This demonstration, in connection with Sidec’s First Protein Tomography™ Symposium, is a unique opportunity to get acquainted with Sidec’s proprietary technology.
Testimonials
from PEGS 2007 attendees:
"The PEGS meeting is the best opportunity that I have found to remain current on the evolving field of therapeutic antibody development."
“Thanks for organizing another great PEGS!”
"It was one of the greatest meetings I’ve been to. I thought that the meeting was very exciting and I enjoyed it a lot."
"I liked the breadth of audience attracted to the conference and I was able to network with some key individuals. It was also useful to visit the booths to discuss new technologies/instrumentation with the vendors.”
“The Phage Display track of the PEGS conference provided a good opportunity to hear about novel technical approaches and applications and learn about the preclinical and clinical development of novel compounds derived by Phage Display. I appreciated that many speakers were willing to delve into the science of their projects which contributed greatly to the value of the meeting”.
“It is always good to hear what has been accomplished using phage display methodologies. What are the new advances is really what will interest me in future meetings.”
“The Phage Display of Antibodies and Peptides meeting offered a comprehensive, well-balanced overview of the latest advances in display technologies and their many applications in bio-engineering and therapeutic research. The excellent selection of case studies, reporting a number of exciting pre-clinical and clinical trials of antibodies (or fragments thereof), provided a spectacular demonstration of the maturity and the promises of these technologies.”
“An extremely well-organized meeting for novel protein engineering approaches”
“The CHI conference was focused on the topics in protein engineering that were relevant both to lead scientists and business developers. The structure of the conference also provided for valuable networking opportunities. If there is one conference to put on your “must attend” list, this is it.”
“The meeting is a privileged forum for sharing and learning about progress made and for networking with industry peers”
“These talks need to be published! I’ve heard information here that I’ve never been aware of before.”
“I think the conference were pretty tight and well organized”
“This was a really interesting conference!”
“I very much enjoyed the conference!”
“The conference was great! I really did enjoy the conference and the interactions.”
|
